News

BioM's articles and press releases about the Bavarian biotechnology sector


Dermagnostix: new capital for better diagnosis of psoriasis and eczema

Der­magnostix, based in Fried­berg and Freiburg, Ger­many, has suc­cess­fully closed its EUR 4.6 mil­lion seed-plus fin­an­cing round. The …

Shanghai Ranking: TUM and LMU best universities in Germany

The "Shang­hai Rank­ing" has rated the Tech­nic­al University of Mu­nich (TUM) as the best Ger­man uni­ver­sity, fol­lowed by the…

Science Minister Blume and Health Minister Holetschek announce the start of the BORN project at BZKF

The Bav­aria-wide On­co­lo­gic­al Ra­di­ology Net­work - 'BORN' for short - of the BZKF uses the op­por­tun­it­ies of di­git­iz­a­tion for…

Benjamin Knier honored with prestigious Sobek Young Investigator Award for Multiple Sclerosis Research

The Sobek Found­a­tion has now honored its award win­ners for the years 2020 to 2022 in a joint ce­re­mony at the Stut­tgart University of…

TUM and WACKER establish Institute for Industrial Biotechnology

With the found­ing of the TUM WACKER In­sti­tute for In­dus­tri­al Bi­o­tech­no­logy, Wack­er Chemie AG and the Tech­nic­al University of…

BioM and Munich Biotech Cluster celebrate its 25th anniversary

On July 27, BioM and the Mu­nich Bi­otech Cluster cel­eb­rated their 25th an­niversary. To­geth­er, they can claim a great suc­cess story.…

Minimally invasive removal of kidney stones: Dymium wins Munich Business Plan Competition

Dy­mi­um de­vel­ops a min­im­ally in­vas­ive treat­ment meth­od for the rem­nant-free re­mov­al of kid­ney stones using mag­net­ic…

NEOsphere Biotechnologies receives new capital to further develop its degrader proteomics platform

NEO­sphere Bi­o­tech­no­lo­gies GmbH from Planegg near Mu­nich an­nounced the com­ple­tion of a Ser­ies A fin­an­cing round to fur­ther…

Third place for Microbify in the final of the Businessplan Wettbewerb Nordbayern of BayStartUP

The life sci­ence star­tup Mi­crobi­fy from Re­gens­burg won third place in the fi­nals of BayStartUP's North­ern Bav­aria Busi­ness Plan…

Munich scores at the Science4Life Business Plan Competition 2022

Fusix Bi­otech, Dy­mi­um and Opsy­on Thera­peut­ics were per­suas­ive in this year's busi­ness plan phase of the Science4Life Ven­ture Cup.

Newsletter

Subscribe

Archive



Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager